Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report
ABSTRACT This study reports a significant clinical outcome following the use of bronchoscopic interventional therapy combined with pembrolizumab for treating pulmonary large cell neuroendocrine carcinoma (LCNEC), showcasing a novel approach in managing this aggressive cancer.
Saved in:
| Main Authors: | Yingyi Fan, Yingying Wang, Yanrong Ji, Shuang Li, Jian Zhang, Xingliang Hao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-09-01
|
| Series: | The Clinical Respiratory Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/crj.70009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Large Cell Neuroendocrine Carcinoma of the Lung in Posttuberculosis Cavity
by: Mansoor C. Abdulla
Published: (2022-10-01) -
Pembrolizumab for treatment-related neuroendocrine prostate carcinoma with a high tumor mutational burden: a case report
by: Keiji Shiba, et al.
Published: (2025-08-01) -
Advances of Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma
by: Jiayi SUN, et al.
Published: (2024-08-01) -
Efficacy of combined surgery and pembrolizumab for the treatment of pulmonary large cell carcinoma: a case report
by: Linguo Gu, et al.
Published: (2024-12-01) -
First-line selpercatinib for a patient with RET fusion-positive pulmonary large cell neuroendocrine carcinoma
by: Tatsuru Eihuku, et al.
Published: (2024-01-01)